
Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Life sciences investment firm building new medicines and technologies for unmet medical needs

Life sciences investing is the work of venBio, a firm that partners with industry leaders to build new medicines and technologies. It concentrates on new therapies where medical need is not yet being met, and it says it looks for teams developing treatments that could have a meaningful effect on patient care. The firm runs several venture funds, and its portfolio activity covers cell therapy, oncology, radiopharmaceuticals and eye disease.
The firm says it considers potential acquisition partners from the outset and sets each company up to meet what those partners will need. That work covers intellectual property, chemistry and manufacturing, and the design of clinical trials, including the indication being treated, the trial design, the endpoints, the statistical power of the study and the regulatory questions that follow.
Its team helps companies choose a development plan that can carry a therapy through to patients. The firm describes this involvement as a way of helping each company make a larger impact, and it says the relationships it builds with the leaders it works alongside are lasting ones.
VenBio is a life sciences investment firm that works with industry leaders to develop new medicines and technologies. Its emphasis is on novel therapeutics for conditions with unmet medical needs. The firm has run several venture funds.
The firm partners with biotech teams and industry leaders. Its news lists portfolio activity in cell therapy, oncology and radiopharmaceuticals, eye disease and other clinical programmes, including public offerings by several portfolio companies.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
No questions yet. Be the first to ask about venBio.
Similar listings buyers compare against this one.

Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

A local venture capital investor co-financing young technology companies alongside private investors

Venture fund dedicated to pet care and animal health startups, run by Digitalis Ventures

Renewable energy investment manager within Schroders Capital, active across the UK, Europe and North America

Early-stage technology investor partnering with founders building software and internet companies in Africa and other under-followed markets

Boston venture fund making early-stage investments in founders chosen for emotional intelligence

Early-stage venture firm backing technical founders from pre-seed to Series A across hardware-led sectors
Everything here links back to the same verified catalogue. Pick your next stop.